AptaBio
aptabio.com
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Our Company 플랫폼 기술기반 First-in-Class 신약개발 전문 기업 Our Company Our Science Our Company Product IR News & PR Careers Contact Us 회사소개 경영진 Apta's Way 연혁 오시는 길 회사소개 플랫폼 기술기반 First-in-Class 신약개발 전문 기업 압타바이오는 독창적인 플랫폼 기술을 바탕으로 난치성 질환에 대한 First-in-Class 혁신 신약을 개발하는 제약바이오 기업으로 2009년에 설립되었습니다.
News
Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)
Aptabio
Read more
Report
Aptabio Obtains Canadian Patent for Non-Alcoholic Steatohepatitis Treatment
아시아경제 이관주 기자 압타바이오는 비알코올성지방간염(NASH) 치료제
Read more
Report
Special Stock Aptabio Confirms COVID-19 Treatment Effectiveness... Preparing to Enter Phase 2 Clinical Trial
Asia Economy Reporter Hyungsoo Park Aptabio, a developer of anticancer and diabetic complication treatments, is seeing a surge in its stock price. T
Read more
Report
People
Sujin Lee
CEO
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data